Revolutionizing Cancer Genomics: AI-Driven Interpretation of Nanopore Sequencing Signals
DOI:
https://doi.org/10.62051/g8rwwe94Keywords:
Nanopore sequencing; deep learning; biomarkers detection; artificial intelligence in genomics; cancer diagnosis.Abstract
Nanopore sequencing technology enables the detailed analysis of biomolecules such as DNA and RNA by detecting variations in ionic current as these molecules traverse nano-scale pores. This method captures nuanced patterns, including sequence context and modification signatures. This research investigates the application of artificial intelligence (AI), particularly deep learning models such as SquiggleNet, NanoDeep, and DeepMod2, in analyzing nanopore sequencing data. The performance metrics of these models are notable, with SquiggleNet achieving an accuracy of 90.8% and an AUC score of 0.817, along with a recall rate of 72.5%. NanoDeep demonstrated an AUC score of up to 0.925 on simulated datasets and an accuracy of 84.9%, while DeepMod2 exhibited varying AUC scores with the highest being 0.903 and recall rates reaching 92.9%. The findings underscore the transformative potential of AI on enhancing clinical diagnosis and customizing medical treatment through rapid and precise biomarker detection. However, despite these promising results, further research and validation are necessary to confirm the efficacy and robustness of these AI models in diverse clinical settings. This research highlights the significant advancements that AI can bring to the field of genomics, especially in cancer diagnostics, but emphasizes the need for continued development and real-world testing to fully realize their potential.
Downloads
References
[1] Siegel R L, Giaquinto A N, Jemal A. Cancer statistics, 2024. CA: a cancer journal for clinicians, 2024, 74(1): 12-49.
[2] Nash Z, Menon U. Ovarian cancer screening: Current status and future directions. Best practice & research Clinical obstetrics & gynaecology, 2020, 65: 32-45.
[3] Smith R A, Andrews K S, Brooks D, et al. Cancer screening in the United States, 2019: A review of current American Cancer Society guidelines and current issues in cancer screening. CA: a cancer journal for clinicians, 2019, 69(3): 184-210.
[4] Chen S, Li M, Weng T, et al. Recent Progresses of Biosensors for the Detection of Lung Cancer Markers. Journal of Materials Chemistry B, 2023,11: 5715-5747.
[5] Singh A, Sharma A, Ahmed A, et al. Recent advances in electrochemical biosensors: Applications, challenges, and future scope. Biosensors, 2021, 11(9): 336.
[6] Wang Y, Zhao Y, Bollas A, et al. Nanopore sequencing technology, bioinformatics and applications. Nature biotechnology, 2021, 39(11): 1348-1365.
[7] Ying Y L, Hu Z L, Zhang S, et al. Nanopore-based technologies beyond DNA sequencing. Nature nanotechnology, 2022, 17(11): 1136-1146.
[8] Kim H J, Choi U J, Kim H, et al. Translocation of DNA and protein through a sequentially polymerized polyurea nanopore. Nanoscale, 2019, 11(2): 444-453.
[9] Lin Y, Zhang Y, Sun H, et al. NanoDeep: a deep learning framework for nanopore adaptive sampling on microbial sequencing. Briefings in Bioinformatics, 2024, 25(1): bbad499.
[10] Bao Y, Wadden J, Erb-Downward J R, et al. SquiggleNet: real-time, direct classification of nanopore signals. Genome biology, 2021, 22: 1-16.
[11] Liu Q, Fang L, Yu G, et al. Detection of DNA base modifications by deep recurrent neural network on Oxford Nanopore sequencing data. Nature communications, 2019, 10(1): 2449.
[12] Ahsan M U, Gouru A, Chan J, et al. A signal processing and deep learning framework for methylation detection using Oxford Nanopore sequencing. Nature Communications, 2024, 15(1): 1448.
Downloads
Published
Conference Proceedings Volume
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.







